Compare Bukit Asam Tbk. (PTBA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bukit Asam Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Bukit Asam Tbk. trades at Rp3,100 (market cap 35.71T, 51.29M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Bukit Asam Tbk. is far larger — about 342× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| PTBA | SCPI | |
|---|---|---|
Market Cap | 35.71T | 104.4B |
Volume | 51.29M | — |
Lot | 512.91K | — |
Turnover | 158.66B | — |
Average Price | 3,093.33 | — |
Value | 158.66B | — |
Indicative Equilibrium Price | 3,100 | — |
Indicative Equilibrium Volume | 15.39K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bukit Asam Tbk.
PT Bukit Asam (Persero) Tbk was established on March 2nd 1981 in Tanjung Enim as PT. Tambang Batubara Bukit Asam. However the mine working have been exploited since 1919 under Government of Netherland Indie. Take over by Japan on 1942, and nationalized by Indonesian Government on 1945. On October 30th 1990, government merged Perum Tambang Batubara, Sawahlunto in the corporate. On 1983, corporate assigned by government to develop coal briquet. Employees 4021 personnel.
Read more on PTBA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
